Learn More
Apexbio Technology LLC Uridine triacetate 4105-38-8 100mg

Supplier: Apexbio Technology LLC C7150100
Uridine triacetate is an orally bioavailable prodrug of uridine It is designed to undergo rapid intestinal absorption followed by enzymatic deacetylation in circulation thereby releasing free uridine Uridine triacetate exerts its biological activity primarily through metabolic conversion to uridine which supports studies of systemic toxicity induced by chemotherapeutic agents such as 5-fluorouracil (5-FU) and capecitabine Based on these pharmacological properties uridine triacetate holds research potential in examining mechanisms underlying chemotherapy-induced cardiac and central nervous system toxicity as well as in studying metabolic events related to uridine homeostasis and therapeutic intervention following drug overdose or excessive chemotherapeutic exposure
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.